• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力中 microRNA 簇的全局通路视图分析。

Global pathway view analysis of microRNA clusters in myasthenia gravis.

机构信息

Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.

College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China.

出版信息

Mol Med Rep. 2019 Mar;19(3):2350-2360. doi: 10.3892/mmr.2019.9845. Epub 2019 Jan 10.

DOI:10.3892/mmr.2019.9845
PMID:30664201
Abstract

The significant roles of microRNAs (miRNAs) in the pathogenesis of myasthenia gravis (MG) have been observed in numerous previous studies. The impact of miRNA clusters on immunity has been demonstrated in previous years; however, the regulation of miRNA clusters in MG remains to be elucidated. In the present study, 245 MG risk genes were collected and 99 MG risk pathways enriched by these genes were identified. A catalog of 126 MG risk miRNAs was then created; the MG risk miRNAs were located on each chromosome and a miRNA cluster was defined as a number of miRNAs with a relative distance of <6 kb on the same sub‑band, same band, same region and same chromosome. Furthermore, enrichment analyses were performed using the target genes of the MG risk miRNA clusters, and a number of risk pathways of each miRNA clusters were identified. As a result, 15 significant miRNA clusters associated with MG were identified. Additionally, the most significant pathways of the miRNA clusters were identified to be enriched on chromosomes 9, 19 and 22, characterized by immunity, infection and carcinoma, suggesting that the mechanism of MG may be associated with certain abnormalities of miRNA clusters on chromosomes 9, 19 and 22. The present study provides novel insight into a global pathway view of miRNA clusters in the pathogenesis of MG.

摘要

许多先前的研究已经观察到 microRNAs(miRNAs)在重症肌无力(MG)发病机制中的重要作用。近年来已经证明了 miRNA 簇对免疫的影响,但 MG 中 miRNA 簇的调节仍有待阐明。在本研究中,收集了 245 个 MG 风险基因,并确定了这些基因富集的 99 个 MG 风险途径。然后创建了一个包含 126 个 MG 风险 miRNA 的目录;MG 风险 miRNA 位于每个染色体上,并且 miRNA 簇被定义为在同一亚带、同一带、同一区域和同一染色体上相对距离<6kb 的多个 miRNA。此外,还对 MG 风险 miRNA 簇的靶基因进行了富集分析,并确定了每个 miRNA 簇的多个风险途径。结果鉴定出与 MG 相关的 15 个重要 miRNA 簇。此外,还发现 miRNA 簇的最重要途径富集在染色体 9、19 和 22 上,特征为免疫、感染和癌,表明 MG 的发病机制可能与染色体 9、19 和 22 上某些 miRNA 簇的异常有关。本研究为 miRNA 簇在 MG 发病机制中的全局途径观点提供了新的见解。

相似文献

1
Global pathway view analysis of microRNA clusters in myasthenia gravis.重症肌无力中 microRNA 簇的全局通路视图分析。
Mol Med Rep. 2019 Mar;19(3):2350-2360. doi: 10.3892/mmr.2019.9845. Epub 2019 Jan 10.
2
Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis.微小RNA调控的药物-信号通路网络构建揭示了重症肌无力的药物再利用候选药物。
Int J Mol Med. 2017 Feb;39(2):268-278. doi: 10.3892/ijmm.2017.2853. Epub 2017 Jan 11.
3
Identifying a polymorphic 'switch' that influences miRNAs' regulation of a myasthenia gravis risk pathway.识别一种影响微小RNA对重症肌无力风险通路调控的多态性“开关”。
PLoS One. 2014 Aug 12;9(8):e104827. doi: 10.1371/journal.pone.0104827. eCollection 2014.
4
Construction of a TF-miRNA-gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravis.构建 TF-miRNA-基因前馈环网络预测重症肌无力的生物标志物和潜在药物。
Sci Rep. 2021 Jan 28;11(1):2416. doi: 10.1038/s41598-021-81962-6.
5
MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis.与重症肌无力胸腺生发中心异位相关的 microRNA 和 mRNA 表达。
PLoS One. 2018 Oct 11;13(10):e0205464. doi: 10.1371/journal.pone.0205464. eCollection 2018.
6
MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine.与重症肌无力治疗反应相关的 microRNA 特征:迈向精准医学的进一步探索。
Pharmacol Res. 2019 Oct;148:104388. doi: 10.1016/j.phrs.2019.104388. Epub 2019 Aug 8.
7
Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues.分析重症肌无力患者胸腺中的 microRNA 表达为该疾病的研究开辟了新的途径。
Autoimmun Rev. 2018 Jun;17(6):588-600. doi: 10.1016/j.autrev.2018.01.008. Epub 2018 Apr 13.
8
A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis.非编码 RNA 在重症肌无力发病机制中的作用研究进展
Int J Mol Sci. 2021 Nov 30;22(23):12964. doi: 10.3390/ijms222312964.
9
Detecting key genes regulated by miRNAs in dysfunctional crosstalk pathway of myasthenia gravis.在重症肌无力功能失调的串扰通路中检测受微小RNA调控的关键基因。
Biomed Res Int. 2015;2015:724715. doi: 10.1155/2015/724715. Epub 2015 Feb 1.
10
A computational screen for mouse signaling pathways targeted by microRNA clusters.针对微小RNA簇靶向的小鼠信号通路的计算筛选。
RNA. 2008 Jul;14(7):1276-83. doi: 10.1261/rna.997708. Epub 2008 May 29.

引用本文的文献

1
Overview of miR-106a Regulatory Roles: from Cancer to Aging.miR-106a调控作用概述:从癌症到衰老
Bioengineering (Basel). 2023 Jul 27;10(8):892. doi: 10.3390/bioengineering10080892.
2
Preferential X Chromosome Inactivation as a Mechanism to Explain Female Preponderance in Myasthenia Gravis.优先 X 染色体失活作为解释重症肌无力女性优势的机制。
Genes (Basel). 2022 Apr 15;13(4):696. doi: 10.3390/genes13040696.
3
Construction of a TF-miRNA-gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravis.
构建 TF-miRNA-基因前馈环网络预测重症肌无力的生物标志物和潜在药物。
Sci Rep. 2021 Jan 28;11(1):2416. doi: 10.1038/s41598-021-81962-6.
4
Emerging Roles of Dysregulated MicroRNAs in Myasthenia Gravis.失调的微小RNA在重症肌无力中的新作用
Front Neurosci. 2020 May 21;14:507. doi: 10.3389/fnins.2020.00507. eCollection 2020.